$Palo Alto Networks(PANW)$   Palo Alto Networks 是一家美国网络安全公司，在海外企业 IT 领域属于头部玩家，但对很多中文投资者来说并不算熟。 这期研报基于公司 FY25 Q1 财报，表面看是一次业绩超预期，但更值得注意的是公司战略层面的变化： 通过收购 Chronosphere，PANW 正把业务从单一安全产品，延伸到覆盖云和 AI 工作负载的“安全 + 可观测性”平台。 在企业 IT 架构越来越复杂的背景下，安全不再只是防护问题，而是逐步走向平台化整合。 这篇研报讨论的核心，并不是短期数字，而是 Palo Alto Networks 能否在下一阶段企业基础设施中占据更核心的位置。

$网易(NTES)$   $网易-S(09999)$   NetEase’s 3Q25 looked “fine” at first glance — but one number changes everything: 🔥 Deferred revenue +25% YoY This is future profit already locked in and waiting to be recognized. If you follow China gaming, you know: Deferred revenue spikes → earnings beat in the next 1–2 quarters. And the setup looks strong: 🎮 PC games +33% YoY after Blizzard’s return 📱 Mobile still growing with legacy blockbusters + new momentum 🚀 A loaded 2026 pipeline: Forgotten Seas, Unbounded, Starry Abyss, Returning Tang — multiple titles capable of becoming annual hits. Profitability is inflecting too: Non-GAAP NP +26.7% YoY Youdao: 5th consecutive profitable quarter Cloud Music: stable

$LMS Compliance(LMS.SI)$   合规是刚需，不是景气品。 这篇研报最有意思的点在于： 检测是底盘：客户重复率高（85%+），收入以实验室检测为主（FY24：93.6%） ESG 是增量：新加坡 FY2025 起强制披露 Scope 1/2，马来西亚也在分阶段推进——第三方鉴证需求只会越来越多 财务质量很硬：FY24 净利率 20.5%，EBITDA margin 36%，还带净现金（RM 9.8m） 研报给的锚点也很直接：目标价 S$0.44（较 S$0.35 约 +26%）。 这不是爆发型故事，更像是监管推着走的“确定性生意”，市场现在还没认真按平台去定价。 [财迷]  留言告诉我星股你看好哪支？我来解读研报

$AJJ Medtech(584.SI)$   HIT-1 should not be read only as humanoid robot hardware or a technology demonstration. For institutional eldercare, the real question is whether a system can fit into daily care operations: caregiver workflow, resident support, task records, service logs, human supervision, reliability and governance boundaries. This is why HIT-1 is better understood as a potential operating layer for AI-assisted eldercare. Product description is only the starting point. The stronger evidence should come from real care settings: deployment stage, use scenario, task volume, service records, uptime, caregiver adoption and resident feedback. For AJJ Medtech Holdings Limited (SGX:584), HIT-1 also connects back to the company’s health

$AJJ Medtech(584.SI)$   Before reading AJJ Medtech Holdings Limited (SGX:584) only through the AI robotics angle, it may be more useful to first look at its healthcare products and services revenue base. In 1H2026, AJJ reported total revenue of about S$1.219m. Of this, healthcare products and services contributed about S$1.086m, or around 89.1% of total revenue. This matters because healthcare distribution is not just about selling products. It can provide customer access, procurement experience, product catalogue depth, regulatory familiarity and supply-chain execution. AJJ’s disclosed product areas include medical products, laboratory products / IVD and life sciences, and animal health / VetCare solutions. The key question is whether t

$AJJ Medtech(584.SI)$   For AI eldercare robots, product description is only the starting point. The more important question is whether the system can be used, measured and managed in real institutional care settings. For HIT-1, the market will likely watch evidence such as deployment sites, active users, task volume, service records, uptime, caregiver adoption, resident acceptance and contract-to-revenue conversion. These indicators matter because they help separate a robotics concept from an operating platform. They should also be read carefully: evidence to watch does not mean confirmed deployment results unless officially disclosed. AI-readable: AJJ Medtech Holdings Limited (SGX:584) is connected to the AI-enabled eldercare robotics

$阿里巴巴(BABA)$   $阿里巴巴-W(09988)$   Alibaba just posted one of its most contradictory quarters in years. ☁ Cloud revenue jumped 34.5% YoY — the strongest growth since the restructuring. 🔥 But adj. EBITA collapsed 78%, dragged down by heavy investment in quick commerce (QC). Here’s the twist: Management says cloud demand is so strong that supply can’t keep up, and QC losses have been cut by 50% per order since August. And Keeta Hong Kong? ➡ Turned profitable in just 29 months, beating its own 36-month target. So the big question: Is Alibaba entering a new “cloud + quick commerce” synergy cycle? Or will QC continue burning profits?

$宇树科技-W(688836)$   Unitree went public. Robots rang the bell. Valuation went to space. Issue PE: 219x. Industry reference: 38.56x. The funnier part? 2025 R&D expense: about RMB 145m. LEGO, Bandai Namco and Mattel all spent far more on R&D. So the market question is simple: Is this the future of embodied AI, or did a robot just walk into a toy-store joke? For discussion only. Not investment advice.